FREE SHIPPING over $40
OVER 10000 FIVE-STAR REVIEWS
5% OFF ALL SUBSCRIPTIONS
100% HAPPINESS GUARANTEE
Analyze Diet
0
American journal of veterinary research2002; 63(7); 987-993; doi: 10.2460/ajvr.2002.63.987

Evaluation of the influence of prostaglandin E2 on recombinant equine interleukin-1beta-stimulated matrix metalloproteinases 1, 3, and 13 and tissue inhibitor of matrix metalloproteinase 1 expression in equine chondrocyte cultures.

Abstract: To determine the effects of prostaglandin E2 (PGE2) on recombinant equine interleukin (IL)-1beta-stimulated expression of matrix metalloproteinases (MMP 1, MMP 3, MMP 13) and tissue inhibitor of matrix metalloproteinase 1 (TIMP 1) in vitro. Methods: Cultured equine chondrocytes. Methods: Stationary monolayers of first-passage chondrocytes were exposed to graduated concentrations of PGE2 with or without a subsaturating dose (50 pg/ml) of recombinant equine IL-1beta (reIL-1beta) to induce expression of MMP 1, MMP 3, MMP 13, and TIMP 1, followed by RNA isolation and northern blotting. In subsequent experiments, gene expression was similarly quantified from mRNA isolated from cultures pretreated with phenylbutazone to quench endogenous PGE2 synthesis, followed by exposure to reIL-1beta and exogenous PGE2 (5 mg/ml) with appropriate controls. Results: Exogenous PGE2 (10 mg/ml) significantly reduced reIL-1beta-induced expression of MMP 1, MMP 3, MMP 13, and TIMP 1. Abrogation of cytokine induction with this dose of PGE2 was comparable to that for dexamethasone (10(-5) M) control. Similarly, pretreatment with phenylbutazone, followed by exposure to relL-1beta and PGE2 (5 mg/ml), was associated with a reduced expression of the genes of interest, an effect that was significant for MMP 1, MMP 13, and TIMP 1. Conclusions: The MMP and TIMP 1 are important mediators in the pathophysiologic events in osteoarthritis. The potential for physiologically relevant regulation of expression of these genes by PGE2 is a consideration in the use of drugs that inhibit prostanoid synthesis in the treatment of equine arthropathies.
Get Full Text
Publication Date: 2002-07-18 PubMed ID: 12118680DOI: 10.2460/ajvr.2002.63.987Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
LinkedInCopy
  • Journal Article
  • Research Support
  • Non-U.S. Gov't
  • Research Support
  • U.S. Gov't
  • Non-P.H.S.

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This research article investigates the effect of prostaglandin E2 (PGE2) on the expression of certain matrix metalloproteinases, specifically MMP 1, MMP 3, MMP 13, and TIMP 1, in horse cartilage cells stimulated by interleukin-1beta. Findings suggest PGE2 can potentially influence the production of these proteins, which could impact the treatment of horse joint diseases.

Objective and Methodology

  • The researchers aimed to determine how PGE2, a natural substance produced in the body that can cause inflammation and pain, influences the way cartilage cells produce various matrix metalloproteinases (MMPs) and tissue inhibitor of matrix metalloproteinases (TIMP1) when stimulated by interleukin-1beta. MMPs are proteins that break down connective tissue, while TIMP1 is a protein that specifically inhibits MMP activity.
  • Experiments involved growing horse-cartilage cells in a lab environment and exposing them to varying concentrations of PGE2, either alone or combined with interleukin-1beta.
  • This experiment was repeated with cells treated with phenylbutazone to stop the production of endogenous PGE2, then the cells were exposed to external PGE2 and interleukin-1beta.
  • Gene expressions were measured and compared among the different treatments.

Results and Findings

  • The researchers discovered that the addition of external PGE2 reduced the production of MMP 1, MMP 3, MMP 13, and TIMP 1 in cells stimulated by interleukin-1beta. This impact was equivalent to the control group treated with dexamethasone, a corticosteroid that reduces inflammation.
  • The inhibitory effect was also observed in the group treated with phenylbutazone and then exposed to PGE2 and interleukin-1beta.

Conclusions and Implications

  • The research suggests that MMPs and TIMP1 play crucial roles in the development of osteoarthritis, a common joint disease in horses. How PGE2 controls the expression of these genes could be important in developing drugs for treating joint disorders in horses.
  • The results also suggest potential implications for treatment protocols: Current treatments for arthropathies often involve the use of nonsteroidal anti-inflammatory drugs, such as phenylbutazone, to inhibit prostaglandin synthesis – however, this may indirectly influence the production of critical MMPs and TIMP1.

Cite This Article

APA
Tung JT, Arnold CE, Alexander LH, Yuzbasiyan-Gurkan V, Venta PJ, Richardson DW, Caron JP. (2002). Evaluation of the influence of prostaglandin E2 on recombinant equine interleukin-1beta-stimulated matrix metalloproteinases 1, 3, and 13 and tissue inhibitor of matrix metalloproteinase 1 expression in equine chondrocyte cultures. Am J Vet Res, 63(7), 987-993. https://doi.org/10.2460/ajvr.2002.63.987

Publication

American journal of veterinary research
ISSN: 0002-9645
NlmUniqueID: 0375011
Country: United States
Language: English
Volume: 63
Issue: 7
Pages: 987-993

Researcher Affiliations

Tung, Jayne T
  • Department of Large Animal Clinical Sciences, Michigan State University, East Lansing 48824, USA.
Arnold, Carolyn E
    Alexander, Lee H
      Yuzbasiyan-Gurkan, Vilma
        Venta, Patrick J
          Richardson, Dean W
            Caron, John P

              MeSH Terms

              • Animals
              • Anti-Inflammatory Agents, Non-Steroidal / pharmacology
              • Blotting, Northern / veterinary
              • Chondrocytes / cytology
              • Chondrocytes / drug effects
              • Chondrocytes / enzymology
              • Dinoprostone / pharmacology
              • Drug Interactions
              • Gene Expression Regulation, Enzymologic / drug effects
              • Horses / metabolism
              • Interleukin-1 / pharmacology
              • Matrix Metalloproteinases / biosynthesis
              • Matrix Metalloproteinases / genetics
              • Phenylbutazone / pharmacology
              • RNA / chemistry
              • RNA / genetics
              • Recombinant Proteins / pharmacology
              • Reverse Transcriptase Polymerase Chain Reaction / veterinary
              • Tissue Inhibitor of Metalloproteinase-1 / biosynthesis
              • Tissue Inhibitor of Metalloproteinase-1 / genetics

              Citations

              This article has been cited 18 times.
              1. Lee YM, Son E, Kim SH, Kim DS. Protective Effects of Glycine soja Leaf and Stem Extract against Chondrocyte Inflammation and Osteoarthritis. Int J Mol Sci 2023 Mar 2;24(5).
                doi: 10.3390/ijms24054829pubmed: 36902256google scholar: lookup
              2. Lu HT, Lu JW, Lee CH, Peng YJ, Lee HS, Chu YH, Ho YJ, Liu FC, Shen PH, Wang CC. Attenuative Effects of Platelet-Rich Plasma on 30 kDa Fibronectin Fragment-Induced MMP-13 Expression Associated with TLR2 Signaling in Osteoarthritic Chondrocytes and Synovial Fibroblasts. J Clin Med 2021 Sep 29;10(19).
                doi: 10.3390/jcm10194496pubmed: 34640514google scholar: lookup
              3. Aravinthan A, Hossain MA, Kim B, Kang CW, Kim NS, Hwang KC, Kim JH. Ginsenoside Rb(1) inhibits monoiodoacetate-induced osteoarthritis in postmenopausal rats through prevention of cartilage degradation. J Ginseng Res 2021 Mar;45(2):287-294.
                doi: 10.1016/j.jgr.2020.01.004pubmed: 33841009google scholar: lookup
              4. Bhatti FU, Karydis A, Lee BS, Deguchi T, Kim DG, Cho H. Understanding Early-Stage Posttraumatic Osteoarthritis for Future Prospects of Diagnosis: from Knee to Temporomandibular Joint. Curr Osteoporos Rep 2021 Apr;19(2):166-174.
                doi: 10.1007/s11914-021-00661-3pubmed: 33523424google scholar: lookup
              5. Villas-Boas IM, Pidde G, Lichtenstein F, Ching ATC, Junqueira-de-Azevedo ILM, DeOcesano-Pereira C, Madureira Trufen CE, Chudzinski-Tavassi AM, Morais KLP, Tambourgi DV. Human Chondrocyte Activation by Toxins From Premolis semirufa, an Amazon Rainforest Moth Caterpillar: Identifying an Osteoarthritis Signature. Front Immunol 2020;11:2191.
                doi: 10.3389/fimmu.2020.02191pubmed: 33072083google scholar: lookup
              6. Donnell JR, Frisbie DD. Use of firocoxib for the treatment of equine osteoarthritis. Vet Med (Auckl) 2014;5:159-168.
                doi: 10.2147/VMRR.S70207pubmed: 32670856google scholar: lookup
              7. To K, Romain K, Mak C, Kamaraj A, Henson F, Khan W. The Treatment of Cartilage Damage Using Human Mesenchymal Stem Cell-Derived Extracellular Vesicles: A Systematic Review of in vivo Studies. Front Bioeng Biotechnol 2020;8:580.
                doi: 10.3389/fbioe.2020.00580pubmed: 32596228google scholar: lookup
              8. Barrachina L, Remacha AR, Romero A, Vitoria A, Albareda J, Prades M, Roca M, Zaragoza P, Vázquez FJ, Rodellar C. Assessment of effectiveness and safety of repeat administration of proinflammatory primed allogeneic mesenchymal stem cells in an equine model of chemically induced osteoarthritis. BMC Vet Res 2018 Aug 17;14(1):241.
                doi: 10.1186/s12917-018-1556-3pubmed: 30119668google scholar: lookup
              9. Yao N, Chen N, Xu X, Sun D, Liu W, Li G, Bi X, Li S, Chen Z, Chen G, Gan H. Protective effect of Shenmai injection on knee articular cartilage of osteoarthritic rabbits and IL-1β-stimulated human chondrocytes. Exp Ther Med 2017 Jun;13(6):3013-3020.
                doi: 10.3892/etm.2017.4349pubmed: 28587374google scholar: lookup
              10. Gari MA, AlKaff M, Alsehli HS, Dallol A, Gari A, Abu-Elmagd M, Kadam R, Abuzinadah MF, Gari M, Abuzenadah AM, Gauthaman K, Alkhatabi H, Abbas MM. Identification of novel genetic variations affecting osteoarthritis patients. BMC Med Genet 2016 Oct 10;17(Suppl 1):68.
                doi: 10.1186/s12881-016-0330-2pubmed: 27766954google scholar: lookup
              11. Izawa T, Mori H, Shinohara T, Mino-Oka A, Hutami IR, Iwasa A, Tanaka E. Rebamipide Attenuates Mandibular Condylar Degeneration in a Murine Model of TMJ-OA by Mediating a Chondroprotective Effect and by Downregulating RANKL-Mediated Osteoclastogenesis. PLoS One 2016;11(4):e0154107.
                doi: 10.1371/journal.pone.0154107pubmed: 27123995google scholar: lookup
              12. Zhong Y, Huang Y, Santoso MB, Wu LD. Sclareol exerts anti-osteoarthritic activities in interleukin-1β-induced rabbit chondrocytes and a rabbit osteoarthritis model. Int J Clin Exp Pathol 2015;8(3):2365-74.
                pubmed: 26045743
              13. Maldonado M, Nam J. The role of changes in extracellular matrix of cartilage in the presence of inflammation on the pathology of osteoarthritis. Biomed Res Int 2013;2013:284873.
                doi: 10.1155/2013/284873pubmed: 24069595google scholar: lookup
              14. Nakashima K, Nakatsuka K, Yamashita K, Kenichi K, Taro H. An in vitro model of cartilage degradation by chondrocytes in a three-dimensional culture system. Int J Biomed Sci 2012 Dec;8(4):249-57.
                pubmed: 23675280
              15. Cheng AW, Stabler TV, Bolognesi M, Kraus VB. Selenomethionine inhibits IL-1β inducible nitric oxide synthase (iNOS) and cyclooxygenase 2 (COX2) expression in primary human chondrocytes. Osteoarthritis Cartilage 2011 Jan;19(1):118-25.
                doi: 10.1016/j.joca.2010.10.019pubmed: 21035557google scholar: lookup
              16. Tchetina EV, Di Battista JA, Zukor DJ, Antoniou J, Poole AR. Prostaglandin PGE2 at very low concentrations suppresses collagen cleavage in cultured human osteoarthritic articular cartilage: this involves a decrease in expression of proinflammatory genes, collagenases and COL10A1, a gene linked to chondrocyte hypertrophy. Arthritis Res Ther 2007;9(4):R75.
                doi: 10.1186/ar2273pubmed: 17683641google scholar: lookup
              17. Jenkins K, Javadi M, Borghaei RC. Interleukin-4 suppresses IL-1-induced expression of matrix metalloproteinase-3 in human gingival fibroblasts. J Periodontol 2004 Feb;75(2):283-91.
                doi: 10.1902/jop.2004.75.2.283pubmed: 15068117google scholar: lookup
              18. Hossain MA, Lim S, Bhilare KD, Alam MJ, Chen B, Vijayakumar A, Yoon H, Kang CW, Kim JH. Bone marrow stem cells incubated with ellipticine regenerate articular cartilage by attenuating inflammation and cartilage degradation in rabbit model. J Vet Sci 2023 Nov;24(6):e83.
                doi: 10.4142/jvs.23128pubmed: 38031520google scholar: lookup
              Subscribe to our newsletter
              Join 100,113 horse owners like you who receive our email updates on horse health and nutrition.